A decade after the KDOQI CKD guidelines: Impact on research

American Journal of Kidney Diseases

Volumn 60, Issue 5, 2012, Pages 701-704

  Coresh, Josef ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALBUMINURIA; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DATA BASE; DIABETES MELLITUS; DIET; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; KIDNEY; KIDNEY FAILURE; MEDICAL EDUCATION; MEDICAL RESEARCH; MINERAL METABOLISM; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PUBLICATION; REVIEW; RISK; UNITED STATES;

EID: 84867558256     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.08.012     Document Type: Editorial

References (39)

1. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39(2) suppl 1 2002 S1 S266
2. C.Y. Hsu, G.M. Chertow Chronic renal confusion: insufficiency, failure, dysfunction, or disease Am J Kidney Dis 36 2 2000 415 418
3. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
4. A.S. Levey, J. Coresh, E. Balk National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2 2003 137 147
5. B.M. Brenner, M.E. Cooper, D. De Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 2001 861 869
6. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 12 2001 851 860
7. A.V. Chobanian, G.L. Bakris, H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report JAMA 289 19 2003 2560 2572
8. J. Coresh, B.C. Astor, T. Greene, G. Eknoyan, A.S. Levey Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 1 2003 1 12
9. J. Coresh, E. Selvin, L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047
10. J. Coresh, B.C. Astor, G. McQuillan Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate Am J Kidney Dis 39 5 2002 920 929
11. G.L. Myers, W.G. Miller, J. Coresh Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program Clin Chem 52 1 2006 5 18
12. College of American Pathologists Current status of reporting estimated glomerular filtration rate (eGFR) for adults http://www.cap.org/apps/docs/ committees/chemistry/current-status-of-reporting-eGFR-2011.pdf Accessed June 10, 2012
13. A.S. Levey, J. Coresh Chronic kidney disease Lancet 379 9811 2012 165 180
14. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
15. M.G. Shlipak, M.J. Sarnak, R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2005 2049 2060
16. A. Kottgen, E. Selvin, L.A. Stevens, A.S. Levey, F. Van Lente, J. Coresh Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 51 3 2008 385 394
17. A. Grubb, S. Blirup-Jensen, V. Lindstrom, C. Schmidt, H. Althaus, I. Zegers First certified reference material for cystatin C in human serum ERM-DA471/IFCC Clin Chem Lab Med 48 11 2010 1619 1621
18. L.A. Inker, C.H. Schmid, H. Tighiouart CKD-EPI Investigators Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 1 2012 20 29
19. A.S. Levey, P.E. de Jong, J. Coresh The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Kidney Int 80 1 2011 17 28
20. D.S. Tuot, L.C. Plantinga, C.Y. Hsu Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction Clin J Am Soc Nephrol 6 8 2011 1838 1844
21. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 5 2003 1050 1065
22. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32(5) suppl 3 1998 S112 S119
23. T. Isakova, H. Xie, W. Yang Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease JAMA 305 23 2011 2432 2439
24. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
25. M.T. James, B.R. Hemmelgarn, N. Wiebe Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study Lancet 376 9758 2010 2096 2103
26. B.R. Hemmelgarn, J. Zhang, B.J. Manns Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate JAMA 303 12 2010 1151 1158
27. B.R. Hemmelgarn, B.J. Manns, A. Lloyd Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 5 2010 423 429
28. R.J. Glassock, C. Winearls An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 23 4 2008 1117 1121
29. A.M. O'Hare, A.I. Choi, D. Bertenthal Age affects outcomes in chronic kidney disease J Am Soc Nephrol 18 10 2007 2758 2765
30. K. Matsushita, M. van der Velde, B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
31. M. van der Velde, K. Matsushita, J. Coresh Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 12 2011 1341 1352
32. R.T. Gansevoort, K. Matsushita, M. van der Velde Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 1 2011 93 104
33. B.C. Astor, K. Matsushita, R.T. Gansevoort Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease A collaborative meta-analysis of kidney disease population cohorts Kidney Int 79 12 2011 1331 1340
34. K. Matsushita, M. Tonelli, A. Lloyd, A.S. Levey, J. Coresh, B.R. Hemmelgarn Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR Am J Kidney Dis 60 2 2012 241 249
35. R.B. Hopkins, A.X. Garg, A. Levin Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease Clin J Am Soc Nephrol 6 6 2011 1248 1257
36. B.J. Barrett, A.X. Garg, R. Goeree A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial Clin J Am Soc Nephrol 6 6 2011 1241 1247
37. C. Baigent, M.J. Landray, C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
38. R. Thadhani, E. Appelbaum, Y. Pritchett Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial JAMA 307 7 2012 674 684
39. P.E. Pergola, P. Raskin, R.D. Toto Bardoxolone methyl and kidney function in CKD with type 2 diabetes N Engl J Med 365 4 2011 327 336